COVID-19 in lung cancer patients receiving ALK/ROS1 inhibitors

Eur J Cancer. 2020 Jun:132:122-124. doi: 10.1016/j.ejca.2020.04.004. Epub 2020 Apr 23.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Betacoronavirus
  • COVID-19
  • China
  • Coronavirus Infections
  • Humans
  • Lung Neoplasms*
  • Pandemics
  • Pneumonia, Viral
  • Protein Kinase Inhibitors
  • Protein-Tyrosine Kinases
  • Proto-Oncogene Proteins
  • Receptor Protein-Tyrosine Kinases
  • SARS-CoV-2
  • Severe acute respiratory syndrome-related coronavirus*

Substances

  • Protein Kinase Inhibitors
  • Proto-Oncogene Proteins
  • Protein-Tyrosine Kinases
  • ROS1 protein, human
  • Receptor Protein-Tyrosine Kinases